DOI QR코드

DOI QR Code

The Benefit of Supplemental Cough Suppression Therapy for Chronic Refractory Cough

만성 난치성 기침에 대한 기침 억제 요법의 효과

  • Yoo, Yong Jun (Department of Otorhinolaryngology-Head and Neck Surgery, Inha University College of Medicine) ;
  • Park, Hye Jin (Department of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Han, Myung Woul (Department of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Kim, Ji Won (Department of Otorhinolaryngology-Head and Neck Surgery, Inha University College of Medicine)
  • 유용준 (인하대학교 의과대학 이비인후과학교실) ;
  • 박혜진 (울산대학교 의과대학 울산대학교병원 이비인후과학교실) ;
  • 한명월 (울산대학교 의과대학 울산대학교병원 이비인후과학교실) ;
  • 김지원 (인하대학교 의과대학 이비인후과학교실)
  • Received : 2022.02.06
  • Accepted : 2022.03.26
  • Published : 2022.04.30

Abstract

Background and Objectives Cough suppression therapy (CST) is a physiotherapy that can be used for patients with chronic refractory cough (CRC). We aimed to investigate the efficacy of CST for CRC. Materials and Method A prospective randomized controlled trial was conducted in 27 patients with CRC. Participants were randomized to receive either standard mucolytic medications for CRC combined with supplemental CST (CST group) or standard medications alone (control group). CST consists of laryngeal hygiene management, humidification, cough suppression technique, breathing method, and counseling. We assessed the symptoms change at baseline and week 4 with the Leicester Cough Questionnaire (LCQ). Secondary efficacy outcomes included the degree of cough Visual Analog Scale (VAS) score (0 to 100 scale). Results From 2019 to 2021, 14 CST group patients and 13 control group patients were included. The improvement was significantly greater in the CST group than in the control group for cough VAS score (36.67 to 13.33 vs. 74.29 to 16.43, p<0.001). Patients in the CST group had a significant improvement in total (70.14 to 107.71, p=0.005), physical (31.42 to 43.86, p=0.015), psychological (23.57 to 40.14, p=0.003), and social (15.14 to 23.71, p=0.005) LCQ scores. However, there was not a significant pre- to post-treatment LCQ score improvement in control group. Conclusion CST might be an effective supplemental intervention for CRC.

Keywords

Acknowledgement

This work was supported by Inha University Research Grant.

References

  1. Morice AH, McGarvey L, Pavord I; British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax 2006;61(Suppl 1):i1-24.
  2. Ford AC, Forman D, Moayyedi P, Morice AH. Cough in the community: A cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 2006;61(11):975-9. https://doi.org/10.1136/thx.2006.060087
  3. Brignall K, Jayaraman B, Birring SS. Quality of life and psychosocial aspects of cough. Lung 2008;186 Suppl 1:S55-8. https://doi.org/10.1007/s00408-007-9034-x
  4. Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: Systematic review. Lung 2014;192(1):75-85. https://doi.org/10.1007/s00408-013-9508-y
  5. Haque RA, Usmani OS, Barnes PJ. Chronic idiopathic cough: A discrete clinical entity? Chest 2005;127(5):1710-3. https://doi.org/10.1378/chest.127.5.1710
  6. Morice AH. Epidemiology of cough. Pulm Pharmacol Ther 2002; 15(3):253-9. https://doi.org/10.1006/pupt.2002.0352
  7. Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. Efficacy of speech pathology management for chronic cough: A randomised placebo controlled trial of treatment efficacy. Thorax 2006;61(12):1065-9. https://doi.org/10.1136/thx.2006.064337
  8. Chamberlain S, Garrod R, Birring SS. Cough suppression therapy: Does it work? Pulm Pharmacol Ther 2013;26(5):524-7. https://doi.org/10.1016/j.pupt.2013.03.012
  9. Gibson PG, Vertigan AE. Speech pathology for chronic cough: A new approach. Pulm Pharmacol Ther 2009;22(2):159-62. https://doi.org/10.1016/j.pupt.2008.11.005
  10. Birring SS, Floyd S, Reilly CC, Cho PSP. Physiotherapy and speech and language therapy intervention for chronic cough. Pulm Pharmacol Ther 2017;47:84-7. https://doi.org/10.1016/j.pupt.2017.04.001
  11. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003;58(4):339-43. https://doi.org/10.1136/thorax.58.4.339
  12. Chamberlain Mitchell SAF, Ellis J, Ludlow S, Pandyan A, Birring SS. Non-pharmacological interventions for chronic cough: The past, present and future. Pulm Pharmacol Ther 2019;56:29-38. https://doi.org/10.1016/j.pupt.2019.02.006
  13. Gibson PG, Vertigan AE. Management of chronic refractory cough. BMJ 2015;351:h5590. https://doi.org/10.1136/bmj.h5590
  14. Ryan NM, Vertigan AE, Bone S, Gibson PG. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough 2010;6:5. https://doi.org/10.1186/1745-9974-6-5
  15. Patel AS, Watkin G, Willig B, Mutalithas K, Bellas H, Garrod R, et al. Improvement in health status following cough-suppression physiotherapy for patients with chronic cough. Chron Respir Dis 2011;8(4): 253-8. https://doi.org/10.1177/1479972311422547
  16. Chamberlain Mitchell SA, Garrod R, Clark L, Douiri A, Parker SM, Ellis J, et al. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: A multicentre randomised control trial. Thorax 2017;72(2):129-36. https://doi.org/10.1136/thoraxjnl-2016-208843
  17. Mitchell SC, Garrod R, Clarke L, Douiri A, Hull J, Chung KF, et al. Breathing pattern changes in refractory chronic cough with physiotherapy speech and language therapy intervention. Eur Respir J 2016; 48(suppl 60):PA1375.
  18. Kapela SL, Vertigan AE, Gibson PG. Speech pathology intervention for chronic refractory cough: A pilot study examining the benefit of using prerecorded videos as an adjunct to therapy. J Voice 2020;34(4):647.e7-14. https://doi.org/10.1016/j.jvoice.2018.12.002
  19. Slovarp LJ, Jette ME, Gillespie AI, Reynolds JE, Barkmeier-Kraemer JM. Evaluation and management outcomes and burdens in patients with refractory chronic cough referred for behavioral cough suppression therapy. Lung 2021;199(3):263-71. https://doi.org/10.1007/s00408-021-00442-w